ID

37648

Beschreibung

Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer

Stichworte

Versionen (1)
  1. 13.08.19 13.08.19 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

13. August 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612

Englisch

Cycle 7

1 Formulare  
  1. StudyEvent: ODM
    1. Cycle 7
Administrative Data
Beschreibung

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Number
Beschreibung

Patient number

Datentyp

integer

Alias
UMLS CUI [1]
C1830427
Day 1-5
Beschreibung

Day 1-5

Alias
UMLS CUI-1
C0008976
UMLS CUI-2
C0449438
Has the cycle been delayed?
Beschreibung

Clinical Trials, Delay of chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
If Yes, please document the reason
Beschreibung

Clinical Trials, Delay of chemotherapy, Reason and justification

Datentyp

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
UMLS CUI [1,3]
C0566251
Please specify
Beschreibung

Clinical Trials, Delay of chemotherapy, Reason and justification

Datentyp

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
UMLS CUI [1,3]
C0566251
Administration of study medication topotecan (oral)
Beschreibung

Administration of study medication topotecan (oral)

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0146224
UMLS CUI-3
C3469597
Day
Beschreibung

Experimental drug, Topotecan, Administration of medication, Day

Datentyp

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C3469597
UMLS CUI [1,4]
C0439228
Date
Beschreibung

Experimental drug, Topotecan, Administration of medication, Date in time

Datentyp

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C3469597
UMLS CUI [1,4]
C0011008
Planned daily dose for this cycle
Beschreibung

Experimental drug, Topotecan, Daily Dose, Planned

Datentyp

text

Maßeinheiten
  • mg/m2
Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C2348070
UMLS CUI [1,4]
C1301732
Administered dose for this cycle
Beschreibung

Experimental drug, Topotecan, Dosage

Datentyp

integer

Maßeinheiten
  • mg
Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0178602
mg
Administration of study medication topotecan (oral)
Beschreibung

Administration of study medication topotecan (oral)

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0146224
UMLS CUI-3
C3469597
Capsules dispensed on
Beschreibung

Experimental drug, Topotecan, Dispense, Date in time

Datentyp

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1880359
UMLS CUI [1,4]
C0011008
Number of 1 mg capsules
Beschreibung

Experimental drug, Topotecan, Capsule, Dispensed Amount

Datentyp

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C0805077
Number of 0,25 mg capsules
Beschreibung

Experimental drug, Topotecan, Capsule, Dispensed Amount

Datentyp

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C0805077
Capsules returned by the patient on
Beschreibung

Experimental drug, Topotecan, Returned, Date in time

Datentyp

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0332156
UMLS CUI [1,4]
C0011008
Number of 1 mg capsules
Beschreibung

Experimental drug, Topotecan, Capsule, Returned Amount

Datentyp

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C2699071
Number of 0,25 mg capsules
Beschreibung

Experimental drug, Topotecan, Capsule, Returned Amount

Datentyp

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C2699071
Has the dose been modified when compared to the previous cycle?
Beschreibung

Experimental drug, Topotecan, Medication dose changed

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
If "yes", please document the reason
Beschreibung

Experimental drug, Topotecan, Medication dose changed, Reason and justification

Datentyp

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
UMLS CUI [1,4]
C0566251
Please specify
Beschreibung

Experimental drug, Topotecan, Medication dose changed, Reason and justification

Datentyp

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
UMLS CUI [1,4]
C0566251
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Cycle 7

1 Formulare
  1. StudyEvent: ODM
    1. Cycle 7
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Patient number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Item Group
Day 1-5
C0008976 (UMLS CUI-1)
C0449438 (UMLS CUI-2)
Clinical Trials, Delay of chemotherapy
Item
Has the cycle been delayed?
boolean
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
Item
If Yes, please document the reason
text
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Clinical Trials, Delay of chemotherapy, Reason and justification
Code List
If Yes, please document the reason
CL Item
hematological AE (1)
CL Item
non-hematological AE (2)
CL Item
Other, please specify (3)
Item
Please specify
text
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Clinical Trials, Delay of chemotherapy, Reason and justification
Code List
Please specify
Item Group
Administration of study medication topotecan (oral)
C0304229 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C3469597 (UMLS CUI-3)
Item
Day
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C3469597 (UMLS CUI [1,3])
C0439228 (UMLS CUI [1,4])
Experimental drug, Topotecan, Administration of medication, Day
Code List
Day
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
Experimental drug, Topotecan, Administration of medication, Date in time
Item
Date
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C3469597 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Item
Planned daily dose for this cycle
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C2348070 (UMLS CUI [1,3])
C1301732 (UMLS CUI [1,4])
Laboratory Procedures, Hematology finding, Visit
Code List
Planned daily dose for this cycle
CL Item
Baseline (1)
CL Item
Day 1 (2)
CL Item
Day 8 (3)
CL Item
Day 15 (4)
Experimental drug, Topotecan, Dosage
Item
Administered dose for this cycle
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Item Group
Administration of study medication topotecan (oral)
C0304229 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C3469597 (UMLS CUI-3)
Experimental drug, Topotecan, Dispense, Date in time
Item
Capsules dispensed on
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1880359 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Dispensed Amount
Item
Number of 1 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Dispensed Amount
Item
Number of 0,25 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Topotecan, Returned, Date in time
Item
Capsules returned by the patient on
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0332156 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Returned Amount
Item
Number of 1 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Returned Amount
Item
Number of 0,25 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Experimental drug, Topotecan, Medication dose changed
Item
Has the dose been modified when compared to the previous cycle?
boolean
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
Item
If "yes", please document the reason
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
Experimental drug, Topotecan, Medication dose changed, Reason and justification
Code List
If "yes", please document the reason
CL Item
hematological AE (1)
CL Item
non-hematological AE (2)
CL Item
Other, please specify (3)
Experimental drug, Topotecan, Medication dose changed, Reason and justification
Item
Please specify
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video